Usha Nuthi
Neurology · Sparks, NVNPI 1497722524
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,867 and has fallen 95.7% since, to $80 in 2025.
Across 158 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$431
- Novartis$426
- AbbVie$362
- Amgen$314
- EMD Serono, Inc.$303
- Sunovion Pharmaceuticals Inc.$227
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,542100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $431 |
| Novartis | 19 | $426 |
| AbbVie(2 entities) | 11 | $362 |
| Amgen | 11 | $314 |
| EMD Serono, Inc. | 15 | $303 |
| Sunovion Pharmaceuticals Inc. | 16 | $227 |
| Mallinckrodt Hospital Products Inc. | 12 | $198 |
| UCB, Inc. | 8 | $171 |
| Lilly USA, LLC | 8 | $140 |
| Sanofi | 7 | $132 |
| Biohaven Pharmaceuticals, Inc. | 13 | $122 |
| Eisai Inc. | 1 | $92 |
| TG Therapeutics, Inc. | 1 | $80 |
| AstraZeneca | 1 | $77 |
| SK Life Science, Inc. | 2 | $69 |
| Adamas Pharmaceuticals, Inc. | 3 | $54 |
| Biogen | 3 | $52 |
| Boston Scientific | 1 | $41 |
| Banner Life Sciences, LLC | 2 | $39 |
| Bristol Myers Squibb | 2 | $37 |
| Acadia Pharmaceuticals Inc | 2 | $33 |
| Nevro Corp. | 1 | $32 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Pfizer | 1 | $22 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Merz North America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,542 in reported general payments places this provider in the 60th percentile of 145 neurology providers in Nevada.
Other neurology in Sparks
- Melissa BlochReno$883K
- Zoltan MariLas Vegas$629K
- Fan ZhangLas Vegas$398K
- le HuaLas Vegas$385K
- Mehdi AnsariniaLas Vegas$306K
- Burton TabaacReno$287K
- Carrie HershLas Vegas$209K
- Shanker DixitLas Vegas$137K
- G BigleyReno$133K
- Charles KamenLas Vegas$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.